Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313233304> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- W4313233304 endingPage "509" @default.
- W4313233304 startingPage "509" @default.
- W4313233304 abstract "Background: Tridax procumbens Linn. is a spreading herb found throughout India. Tridax procumbens is known for several potential therapeutic effects like antiviral, antioxidant, anti-infective, wound healing, insecticidal and anti-inflammatory, hepatoprotective, and antidiabetic. Novel therapies for inflammation are essential to overcome the adverse effects of existing anti-inflammatory drugs. Thus, this study was designed to evaluate anti-inflammatory activity in the experimental animal. Objective: To evaluate anti-inflammatory efficacy in experimental animalMaterials and Methods: Tridax procumbens plant leaves were taken for the study. The Plant extraction was prepared by using the Soxhlet apparatus. The ethanolic extract was used as a test drug. Indomethacin and Dexamethasone were used as control drugs. Wistar rats weighing 150g to -200g were used in the study. Results: At dosages of 200 and 400 mg kg-1, the ethanolic leaf extracts of Tridax Procumbens demonstrated substantial anti-inflammatory activity against Irish Moss-triggered inflammation. After 3 hours, 400 mgkg-1 showed a significant reduction in inflammation (48 percent), with the impact increasing after 3 hours (52 percent). The anti-inflammatory efficacy of Tridax Procumbens ethanol (EtOH) extracts was substantial and comparable to that of indomethacin (10 mg/kg). Tridax procumbens ‘s Ethanol (EtOH) leaf extract at a dose of 200 and 400 mgkg-1, demonstrated considerable anti-inflammatory action. The average weight of granulomatous surrounding tissue in the threading was considerably smaller in the Tridax procumbens extraction group after 7 days than in the comparison group. The 400 mg kg-1 dose was shown to be the most effective of the two. the greatest reduction in the production of granuloma tissue. Tridax procumbens at doses of 200 mg/kg and 400 mg/kg resulted in substantial reductions in granuloma weights of 38.16 ± 0.04 (7.4 percent inhibition) and 34.58 ± 0.04 (16.1 percent inhibition), respectively. The lower dose of 400 mg/kg resulted in a little lesser reduction in granumola weight than the conventional medication dexamethasone (28.92 ± 0.04). (29.8 percent inhibition). Conclusion: The present study concludes that Tridax Procumbens possess anti-inflammatory effects in animal models." @default.
- W4313233304 created "2023-01-06" @default.
- W4313233304 creator A5022899643 @default.
- W4313233304 creator A5047629453 @default.
- W4313233304 creator A5072892532 @default.
- W4313233304 creator A5084169006 @default.
- W4313233304 creator A5090982933 @default.
- W4313233304 date "2022-01-01" @default.
- W4313233304 modified "2023-10-18" @default.
- W4313233304 title "Assessment of anti-inflammatory activity of Tridax procumbens in wistar rats" @default.
- W4313233304 cites W2055276640 @default.
- W4313233304 cites W2069978879 @default.
- W4313233304 cites W2135768775 @default.
- W4313233304 cites W3034192038 @default.
- W4313233304 doi "https://doi.org/10.4103/mgmj.mgmj_45_22" @default.
- W4313233304 hasPublicationYear "2022" @default.
- W4313233304 type Work @default.
- W4313233304 citedByCount "0" @default.
- W4313233304 crossrefType "journal-article" @default.
- W4313233304 hasAuthorship W4313233304A5022899643 @default.
- W4313233304 hasAuthorship W4313233304A5047629453 @default.
- W4313233304 hasAuthorship W4313233304A5072892532 @default.
- W4313233304 hasAuthorship W4313233304A5084169006 @default.
- W4313233304 hasAuthorship W4313233304A5090982933 @default.
- W4313233304 hasBestOaLocation W43132333041 @default.
- W4313233304 hasConcept C2779703632 @default.
- W4313233304 hasConcept C2779824472 @default.
- W4313233304 hasConcept C2991655182 @default.
- W4313233304 hasConcept C556039675 @default.
- W4313233304 hasConcept C71924100 @default.
- W4313233304 hasConcept C98274493 @default.
- W4313233304 hasConceptScore W4313233304C2779703632 @default.
- W4313233304 hasConceptScore W4313233304C2779824472 @default.
- W4313233304 hasConceptScore W4313233304C2991655182 @default.
- W4313233304 hasConceptScore W4313233304C556039675 @default.
- W4313233304 hasConceptScore W4313233304C71924100 @default.
- W4313233304 hasConceptScore W4313233304C98274493 @default.
- W4313233304 hasIssue "4" @default.
- W4313233304 hasLocation W43132333041 @default.
- W4313233304 hasOpenAccess W4313233304 @default.
- W4313233304 hasPrimaryLocation W43132333041 @default.
- W4313233304 hasRelatedWork W190579277 @default.
- W4313233304 hasRelatedWork W2008213310 @default.
- W4313233304 hasRelatedWork W2051361933 @default.
- W4313233304 hasRelatedWork W2314951325 @default.
- W4313233304 hasRelatedWork W2335334544 @default.
- W4313233304 hasRelatedWork W2361263582 @default.
- W4313233304 hasRelatedWork W2391594582 @default.
- W4313233304 hasRelatedWork W2393610146 @default.
- W4313233304 hasRelatedWork W4234462719 @default.
- W4313233304 hasRelatedWork W2942791239 @default.
- W4313233304 hasVolume "9" @default.
- W4313233304 isParatext "false" @default.
- W4313233304 isRetracted "false" @default.
- W4313233304 workType "article" @default.